Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms HP C13, Hyperpolarized (HP) bicarbonate 13 (13C) |
Target- |
Action enhancers |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Localized Prostate Carcinoma | Phase 1 | United States | 06 Jul 2023 |





